IL6 and neoplasm: Our results suggest a feed-forward signaling loop between tumor-derived IL-6, skeletal muscle steatosis and production of sIL6R, and adipose tissue IL-6 production working in concert to exacerbate skeletal muscle wasting in PDAC.